PRESS RELEASE published on 05/14/2024 at 22:05, 2 years ago Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website Clinical Development Collaborations Protagonist Therapeutics Rusfertide EHA Congress
Published on 05/18/2026 at 22:30, 12 minutes ago Ondas Inc. Stockholders: Vote Now to Ensure Quorum for Annual Meeting
Published on 05/18/2026 at 14:37, 8 hours 5 minutes ago Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Published on 05/18/2026 at 14:30, 8 hours 12 minutes ago Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Published on 05/18/2026 at 20:54, 1 hour 48 minutes ago Freelance.com: chiffre d’Affaires 1er trimestre 2026 : 275,3 M€ (+4%)
Published on 05/18/2026 at 20:40, 2 hours 2 minutes ago Aramco and Pasqal launch Saudi Arabia's first Quantum Computer and Middle East's first commercial Quantum Computing as a Service platform
Published on 05/18/2026 at 20:35, 2 hours 7 minutes ago Africa Finance Corporation Approves US$100 Million Commitment to Africa-Focused Technology Fund Managers to Accelerate Africa’s Digital Industrialisation
Published on 05/18/2026 at 19:00, 3 hours 42 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 11 MAI 2026 au 15 MAI 2026
Published on 05/18/2026 at 22:25, 17 minutes ago Résultats de l’offre publique de retrait et mise en œuvre du retrait obligatoire à venir sur les titres TERACT
Published on 05/18/2026 at 22:25, 17 minutes ago Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:36, 4 hours 6 minutes ago Déclaration des transactions sur actions propres réalisées du 11/05/2026 au 17/05/2026
Published on 05/18/2026 at 18:30, 4 hours 12 minutes ago ALPOU - Groupe POULAILLON - Dépôt du projet de note en réponse à l'offre publique d'achat simplifiée
Published on 05/18/2026 at 18:23, 4 hours 19 minutes ago 260518 BENETEAU Transactions sur actions propres